Market Trends– category –
-
US Stem Cell Manufacturing Market Projected to Reach $40.40 Billion, Driven by iPSC Adoption and Automated Systems: Market Report
openPR.com USA Overview This article summarizes a market research report distributed via openPR.com, predicting substantial growth in the U.S. stem cell manufacturing market, driven by increased iPSC adoption and automated closed system ... -
Digital Biomanufacturing Market Projected to Reach $66.14 Billion by 2034, Driven by Automation and AI: Market Research Report
Fortune Business Insights Global Overview This article summarizes a Digital Biomanufacturing Market research report from Fortune Business Insights. The report projects the digital biomanufacturing market will reach $66.14 billion by 2034... -
Regulatory Complexity Challenges Cell-Cultivated Meat in the US, Highlighting Issues Between Federal Approval and State Legislation
PetfoodIndustry USA Overview The regulatory landscape for cell-cultivated meat products in the United States is becoming increasingly complex, posing challenges for manufacturers due to a mix of federal and state regulations. Despite USD... -
EU Parliament Passes Ban on ‘Meat’ Labeling for Cultivated and Plant-Based Foods, Impacting European Cultivated Meat Market
Cultivated-X Europe Overview The European Parliament has overwhelmingly approved a regulation banning the use of certain meat-related terms for plant-based and cultivated foods. This legislative action formally defines meat as the "edibl... -
Pharmaceutical CDMO Market Report: Capital Investments and Advanced Therapies Drive Growth
Global Market Insights Global Overview This article provides an overview of the Pharmaceutical CDMO Market research report published by Global Market Insights. The report highlights significant capital investments and major expansions wi... -
Cell Therapy Startups Like Orca Bio and Allogene Lead Cancer & Autoimmune Disease Treatment with Off-the-Shelf Platforms
New Market Pitch USA Overview Cell therapy startups such as Orca Bio and Allogene, utilizing off-the-shelf platforms, are spearheading advancements in allogeneic and iPSC-derived therapies for cancer and autoimmune diseases. Key differen... -
Genedata Establishes New Standard for Biopharma Quality Control with NGS, Ensuring Genetic Stability in CGT
Genedata Switzerland Overview Genedata highlights Next-Generation Sequencing (NGS) as a powerful analytical tool for biopharmaceutical quality control (QC). NGS offers GxP-compliant workflows and supports data integrity and streamlined c... -
Data Integrity and ALCOA+ Compliance Critical for Bioprocessing Lab Managers: Addressing Regulatory Requirements with Digital Solutions
LabManager.com USA Overview An article highlights the critical importance of data integrity and ALCOA+ compliance for bioprocessing lab managers. Maintaining ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate, Complete, C... -
Bispecific Antibody CDMO Market to Surge to $603.13 Billion by 2035, Driven by Diverse Asymmetric Formats
PharmaSource UK Overview This article outlines a market research report from PharmaSource on the bispecific antibody CDMO market, projected to skyrocket from $25.94 billion in 2026 to approximately $603.13 billion by 2035. A key market t... -
EU NK Cell Market Projected for Twofold Growth by 2035, Driven by Increasing Allogeneic NK Cell Therapy Approvals
IndexBox USA Overview This article outlines a report from IndexBox on the European Union's NK cell market, which is expected to double in size between 2026 and 2035. This growth is primarily driven by the approval and commercial launch o...
